X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (16) 16
male (10) 10
oncology (10) 10
aged (9) 9
female (9) 9
elderly (6) 6
aged, 80 and over (5) 5
adult (4) 4
care and treatment (4) 4
geriatric oncology (4) 4
hematology (4) 4
italy (4) 4
retrospective studies (4) 4
age factors (3) 3
aged patients (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
cancer patients (3) 3
cell lung-cancer (3) 3
chemotherapy (3) 3
chemotherapy, adjuvant (3) 3
colon cancer (3) 3
colorectal-cancer (3) 3
cystic fibrosis (3) 3
fluorouracil (3) 3
hematology, oncology and palliative medicine (3) 3
hepatitis (3) 3
hospitals (3) 3
middle aged (3) 3
neoplasm staging (3) 3
surveys and questionnaires (3) 3
adjuvant (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
blood (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
cancer (2) 2
capecitabine (2) 2
carcinoma (2) 2
clinical outcomes (2) 2
colonic neoplasms - drug therapy (2) 2
colonic neoplasms - pathology (2) 2
colony-stimulating factor (2) 2
colorectal cancer (2) 2
deoxycytidine - analogs & derivatives (2) 2
deoxycytidine - therapeutic use (2) 2
disease (2) 2
expression (2) 2
fibrosis (2) 2
fluorouracil - administration & dosage (2) 2
fluorouracil - therapeutic use (2) 2
health aspects (2) 2
hepatology (2) 2
immunology (2) 2
infection (2) 2
infections (2) 2
infectious diseases (2) 2
interferon (2) 2
leucovorin (2) 2
leucovorin - administration & dosage (2) 2
liver (2) 2
liver diseases (2) 2
medical research (2) 2
medicine (2) 2
men (2) 2
mice (2) 2
multidisciplinary sciences (2) 2
neoplasms - drug therapy (2) 2
palliative care (2) 2
palliative chemotherapy (2) 2
patients (2) 2
phase-ii (2) 2
phase-ii trial (2) 2
physiological aspects (2) 2
physiology (2) 2
research article (2) 2
review (2) 2
ribavirin (2) 2
science (2) 2
survival (2) 2
t-cells (2) 2
therapy (2) 2
toxicity (2) 2
transplants & implants (2) 2
1st-line treatment (1) 1
abacavir-lamivudine (1) 1
activation (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - immunology (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adjuvant chemotherapy (1) 1
adult; aged; aged, 80 and over; antiviral agents; drug therapy, combination; female; hepatitis c; humans; incidence; liver diseases; male; middle aged; prospective studies; biochemistry, genetics and molecular biology; agricultural and biological sciences (1) 1
advanced breast-cancer (1) 1
advanced colorectal-cancer (1) 1
advanced pancreatic adenocarcinoma (1) 1
affinity (1) 1
age of onset (1) 1
aids (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185728 - e0185728
Journal Article
AJP - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 08/2008, Volume 295, Issue 2, pp. L336 - 347
1 Laboratory of Molecular Pathology, Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona and 2 Department of Pathology, Section of... 
Proteins | Cystic fibrosis | Biochemistry | Lungs | Proteases | Life Sciences | Human health and pathology | Pharmacology | Pharmaceutical sciences | Tissues and Organs
Journal Article
by Palummieri, Antonio and De Carli, Gabriella and Rosenthal, Éric and Cacoub, Patrice and Mussini, Cristina and Puro, Vincenzo and Ladisa, Nicoletta and Maggiolo, Franco and Rizzi, Marco and Calza, Leonardo and Colangeli, Vincenzo and Girometti, Nicolò and Ferraresi, Alice and Focà, Emanuele and Giorgetti, Pier Francesco and Pezzoli, Maria Chiara and Celesia, Benedetto Maurizio and Pinzone, Marilia Rita and Bruno, Tiziana and Viada, Alberto and Vitullo, Davide and Guardigni, Viola and Sighinolfi, Laura and Ambu, Silvia and Bartolozzi, Dario and Campolmi, Irene and Meli, Massimo and Pozzi, Marco and Sterrantino, Gaetana and Matarazzo, Filippo and Purificato, Francesco and Anzalone, Enza and Luciano, Sarracino and Lichtner, Miriam and Raffaella, Marocco and Mercurio, Vito Sante and Lorena, Paula Castelli and Martorelli, Paoli and Linzalone, Angela and Esoka, Franklyn and Raise, Eseme Enzo and Bossolasco, Simona and Castagna, Antonella and Cernuschi, Massimo and Cinque, Paola and Fumagalli, Luca and Gaiera, Giovanni and Gianotti, Nicola and Guffanti, Monica and Maillard, Miriam and Nozza, Silvia and Spagnuolo, Vincenzo and Uberti-Foppa, Caterina and Borghi, Vanni and Cristina Mussini, Mussini and Chessa, Luchino and Matta, Laura and Pasetto, Maria Cristina and D'Esposito, Giuseppe and Franco, Alfredo and Izzo, Crescenzo Maria and Manzillo, Elio and Marocco, Alessandro and Micillo, Raffaele and Pizzella, Teresa and Martini, Salvatore and Moretti, Maria Vittoria and Schiaroli, Elisabetta and Catalani, Corrado and Giorgi, Marina and Menichini, Beatrice and Trezzi, Michele and Migliore, Simona and Ballardini, Giuseppe and Barchi, Enrico and Garlassi, Elisa and Magnani, Giacomo and Prati, Francesca and Testa, Lucia and Ursitti, Maria Alessandra and Zoboli, Giuliana and Teti, Elisabetta and Buonomini, Anna Rita and Cerva, Carlotta and Giovanni D'Anna, D'Anna and Ilari, Barbara and Malagnino, Vincenzo and Sarmati, Loredana and Ammassari, Adriana and Bellagamba, Rita and Evangelo, Boumis and Cicalini, Stefania and Liuzzi, Giuseppina and Loiacono, Laura and Migliorisi, Paolo and Nicastri, Emanuele and Pinnetti, Carmela and Sampaolesi, Alessandro and Tommasi, Chiara and Zaccarelli, Mauro and ... and PrEPventHIV Italy Study Grp and PrEPventHIV Italy Study Group and the PrEPventHIV Italy Study Group
BMC Infectious Diseases, ISSN 1471-2334, 11/2017, Volume 17, Issue 1, pp. 734 - 734
Background: Before Pre-Exposure Prophylaxis (PrEP) was officially recommended and made available, a few surveys among gay and bisexual men, and persons living... 
HIV physicians | Persons Living with HIV/AIDS (PLWHA) | HIV prevention | Pre-Exposure Prophylaxis (PrEP) | Anti-HIV agents | INFECTIOUS DISEASES | MEN | PREVENTION | PREP | INFECTION | FRANCE | Prevention | Antiviral agents | Usage | Antibiotics | Educational aspects | HIV patients | Dosage and administration | Research | Drug therapy | HIV infection | Health aspects | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, pp. e0146086 - e0146086
Background Natural killer cells are involved in the complex mechanisms underlying autoimmune diseases but few studies have investigated their role in... 
NK CELLS | MULTIDISCIPLINARY SCIENCES | PRIMARY BILIARY-CIRRHOSIS | SUSCEPTIBILITY | DISEASE | GENE KIR2DS1 | MAJOR HISTOCOMPATIBILITY COMPLEX | POSSIBLE ASSOCIATION | KIRS | T-CELLS | PRIMARY SCLEROSING CHOLANGITIS | Haplotypes | Liver - pathology | Humans | Middle Aged | Male | Killer Cells, Natural - pathology | Receptors, KIR3DL1 - immunology | Case-Control Studies | Hepatitis, Autoimmune - pathology | Liver - immunology | HLA-C Antigens - immunology | Gene Expression - immunology | Killer Cells, Natural - immunology | Adult | Female | HLA-B18 Antigen - genetics | HLA-DR3 Antigen - immunology | Hepatitis, Autoimmune - genetics | HLA-B Antigens - genetics | Hepatitis, Autoimmune - diagnosis | Receptors, KIR2DL3 - genetics | Receptors, KIR - genetics | HLA-B Antigens - immunology | Hepatitis, Autoimmune - immunology | Biomarkers - blood | Receptors, KIR3DL1 - genetics | HLA-B18 Antigen - immunology | HLA-DR3 Antigen - genetics | Outpatients | Age of Onset | Aged | HLA-C Antigens - genetics | Receptors, KIR - immunology | Receptors, KIR2DL3 - immunology | Immunoglobulins | Killer cells | Chronic active hepatitis | HLA class II antigens | Ligands (Biochemistry) | Physiological aspects | Genetic aspects | Health aspects | KIR protein | Regulators | Transplants & implants | Immunoglobulin-like receptors | Arthritis | Hepatitis | Receptors | Immunology | Hepatology | Killer cell immunoglobulin-like receptors | Bone marrow | Genetics | Natural killer cells | Antigens | Liver diseases | Internal medicine | Potassium channels (inwardly-rectifying) | Hematology | Immune response (cell-mediated) | Patients | Medicine | Hospitals | Affinity | Ligands | Histocompatibility antigen HLA | Autoimmune diseases | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 20, pp. 3548 - 3557
Journal Article
Cancer Research, ISSN 0008-5472, 03/2005, Volume 65, Issue 5, pp. 1693 - 1699
Journal Article
Vaccine, ISSN 0264-410X, 04/2010, Volume 28, Issue 20, p. 3548
  De novoexpression of B7-1 impaired tumorigenicity of TRAMP-C2 mouse prostate adenocarcinoma (TRAMP-C2/B7), but it did not elicit a protective response... 
Plasmids | T cell receptors | Experiments | Immune system | Tumors
Journal Article
Vaccine, ISSN 0264-410X, 04/2010, Volume 28, Issue 20, pp. 3548 - 3557
De novo expression of B7-1 impaired tumorigenicity of TRAMP-C2 mouse prostate adenocarcinoma (TRAMP-C2/B7), but it did not elicit a protective response against... 
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 05/2008, Volume 28, Issue 3B, pp. 1813 - 1820
Background: Palliative chemotherapy significantly reduces mortality in patients with stage IV colon cancer, but is less prescribed with rising age. In this... 
Elderly | Colon cancer | Palliative chemotherapy | 1ST-LINE TREATMENT | MULTICENTER RANDOMIZED-TRIAL | LEUCOVORIN | ONCOLOGY | elderly | colon cancer | palliative chemotherapy | OXALIPLATIN | FLUOROURACIL | METASTATIC COLORECTAL-CANCER | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Capecitabine | Colonic Neoplasms - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Palliative Care - utilization | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Uracil - administration & dosage | Fluorouracil - adverse effects | Oncology Service, Hospital | Aged, 80 and over | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Retrospective Studies | Camptothecin - analogs & derivatives | Medical Oncology - methods | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Tegafur - administration & dosage | Italy | Aged | Neoplasm Staging | Mitomycin - administration & dosage | Deoxycytidine - analogs & derivatives | Palliative Care - methods | Index Medicus
Journal Article
The American Journal of Physiology, ISSN 0002-9513, 08/2008, Volume 295, Issue 2, p. L336
The most common mutation of the cystic fibrosis (CF) gene, the deletion of Phe508, encodes a protein ([DELTA]F508-CFTR) that fails to fold properly, thus... 
Evaluation | Biological transport | Cystic fibrosis | Development and progression | Serum albumin | Properties | Membrane proteins
Journal Article